FlexGen
Leiden
About FlexGen
FlexGen is an innovative biotech company based in Leiden, the Netherlands. FlexGen is a spin-off from Leiden University Medical Centre (LUMC) and Dutch Space (part of EADS) and has proprietary technologies for laser based in-situ synthesis of oligonucleotides and other biomolecules. FlexGen commercializes the FlexArrayer, a bench-top instrument for custom microarray and oligopool synthesis. FlexGen works at the forefront of innovative microarray and oligopool applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Funding stage: Private Equity
- Last round: Private Equity (Mar 2009)
- Website: flexgen.nl
- Phone: +31 7133222
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/flexgen-2433581 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.